Donna Valencia has over 10 years of relevant Drug Safety, Pharmacovigilance and Medical Affairs experience in the Pharma and Biotech industries at companies such as Ikaria, Pfizer and currently at Mesoblast.  Her experience in medicinal products, medical devices and advanced therapy medicinal products including allogeneic mesenchymal precursor and stem cells includes PV operations, signal detection and surveillance, risk management/RMPs, medical writing, aggregate reports, CRO management, Sponsor transfer of clinical trials and Immunogenicity. Prior to industry, Donna worked as a Pharmacist for a few years.  She has her BS in Physiology and Neurobiology and PharmD/MBA from the University of Maryland.